These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30352101)

  • 1. The economic burden of CIDP in the United States: A case-control study.
    Divino V; Mallick R; DeKoven M; Krishnarajah G
    PLoS One; 2018; 13(10):e0206205. PubMed ID: 30352101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden and managed care implications of chronic inflammatory demyelinating polyneuropathy.
    Owens GM
    Am J Manag Care; 2018 Sep; 24(17 Suppl):S380-S384. PubMed ID: 30312033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
    Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
    J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
    Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
    Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic burden of breakthrough seizures.
    Divino V; Petrilla AA; Bollu V; Velez F; Ettinger A; Makin C
    Epilepsy Behav; 2015 Oct; 51():40-7. PubMed ID: 26255884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study.
    Elsaid MI; John T; Li Y; Koduru S; Ali SZ; Catalano C; Narayanan N; Rustgi VK
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1377-1386. PubMed ID: 31778618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient demographics and health plan paid costs in chronic inflammatory demyelinating polyneuropathy.
    Guptill JT; Bromberg MB; Zhu L; Sharma BK; Thompson AR; Krueger A; Sanders DB
    Muscle Nerve; 2014 Jul; 50(1):47-51. PubMed ID: 24639235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
    Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
    Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
    Lin J; Lingohr-Smith M; Kwong WJ
    J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States.
    Soliman AM; Surrey E; Bonafede M; Nelson JK; Castelli-Haley J
    Adv Ther; 2018 Mar; 35(3):408-423. PubMed ID: 29450864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings.
    Black J; Reaven NL; Funk SE; McGaughey K; Ohayon M; Guilleminault C; Ruoff C; Mignot E
    Sleep Med; 2014 May; 15(5):522-9. PubMed ID: 24768358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
    Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
    J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Nov; 9(6):377-87. PubMed ID: 21888449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
    Strand V; Shah R; Atzinger C; Zhou J; Clewell J; Ganguli A; Tundia N
    Curr Med Res Opin; 2020 Jan; 36(1):161-168. PubMed ID: 31433680
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs.
    Darbà J; Marsà A
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):665-670. PubMed ID: 34720023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.